Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.

Wien Klin Wochenschr

Department of Neurology, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany.

Published: December 2012

Two symptomatic patients with heterozygous carnitine palmitoyltransferase II (CPT II) deficiency are reported. Patient 1, a 21-year-old female professional tennis player, suffered from exercise-induced attacks of muscle pain, burning sensations and proximal weakness. Patient 2, a 30-year-old male amateur marathon runner developed muscle cramps and rhabdomyolysis upon extensive exercise and insolation-induced fever. In both patients, the common p.S113L mutation was found in heterozygote state. No second mutation could be found upon sequencing of all the exons of CPT2 gene including exon-intron boundaries. Biochemically, residual CPT activity in muscle homogenate upon inhibition by malonyl-CoA and Triton-X-100 was intermediate between controls and patients with mutations on both alleles. Although CPT II deficiency is an autosomal recessive disorder, the reported patients indicate that heterozygotes might also have typical attacks of myalgia, pareses or rhabdomyolysis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-012-0296-9DOI Listing

Publication Analysis

Top Keywords

cpt deficiency
12
heterozygous carnitine
8
carnitine palmitoyltransferase
8
palmitoyltransferase cpt
8
clinically symptomatic
4
symptomatic heterozygous
4
cpt
4
deficiency symptomatic
4
patients
4
symptomatic patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!